Synthesis and Transcriptional Regulation
Matrix metalloproteinases belong to the class of inducible enzymes. This means that under normal conditions, their tissue concentration is maintained at a very low level, and massive synthesis is triggered only in response to specific stimuli.
The production of MMPs is tightly controlled at the transcription stage. The primary regulatory molecules capable of initiating or modulating the transcription of metalloproteinase genes include:
- Cytokines (e.g., interleukin-1, IL-1);
- Sex hormones (estrogen, progesterone);
- Growth factors (epidermal growth factor EGF, platelet-derived growth factor PDGF);
- Prostaglandins.
In addition to chemical signals, phagocytosis and mechanical stress on cells can also stimulate MMP gene expression.
Activation and Inhibition Mechanisms
A small reserve of metalloproteinases is always present in the extracellular matrix, but they remain in an inactive form (as zymogens).
Enzyme activation occurs post-translationally via partial proteolysis. For the enzyme to become active, an inhibitory peptide fragment must be cleaved off. This process is catalyzed by activators such as plasmin, urokinase, and other proteases. Furthermore, the MMP family is characterized by autoactivation—a situation where already active metalloproteinase molecules cleave and activate their inactive counterparts.
Inhibition of activity is mediated by small specific proteins known as tissue inhibitors of matrix metalloproteinases (TIMPs).
- They exhibit high specificity precisely for MMPs.
- They form stable complexes with most members of this enzyme family.
- They can bind to both active and inactive forms of metalloproteinases, reliably blocking their function.
In turn, TIMP inhibitors themselves can be degraded during proteolysis. The cleavage of inhibitors is carried out by enzymes such as trypsin, chymotrypsin, stromelysin-3, and neutrophil elastase, leading to the release and a sharp surge of MMP activity at the local site.
Example of MMP Action: Collagenase
A typical representative of the matrix metalloproteinase family is collagenase.
Reaction Mechanism: Collagenase specifically cleaves peptide bonds directly within the rigid helical region of the collagen molecule. The bond breakage typically occurs between glycine and leucine or glycine and isoleucine amino acids.
Action Result: The long collagen molecule breaks down into two fragments, corresponding roughly to 3/4 and 1/4 of its original length. Following this cleavage, these fragments irreversibly lose their tight helical structure. The unfolded protein chain becomes vulnerable and accessible to hydrolysis by other, less specific proteases—gelatinases and various peptidases.
In healthy tissue, collagenase exhibits virtually no activity for three reasons:
- Synthesis as a zymogen: the enzyme is secreted by cells as an inactive precursor—procollagenase.
- Presence of tissue inhibitors: TIMP proteins rapidly bind any accidentally activated molecule.
- Compartmentalization: the enzyme is released not randomly, but strictly locally and only when there is a justified need (e.g., for tissue remodeling or at a site of inflammation).
Physiological and Pathological Roles
The balance between MMP synthesis, their activators, and inhibitors is critically important for the organism.
Normally, metalloproteinases ensure:
- Embryonic development processes (requiring continuous tissue restructuring);
- The formation of an adequate immune response.
In pathology, when excessive and uncontrolled MMP activity is observed, they act as destructive factors:
- They provoke barrier permeability defects and destruction of the blood-brain barrier;
- They cause severe degradation of articular cartilage, which is a key pathogenetic mechanism in rheumatoid arthritis and osteoarthritis;
- They contribute to the development of various cardiovascular diseases by remodeling the vascular wall and myocardial tissue.